5-7 December 2017

London, UK

Save £850 – Register Now

Main Menu About Main Menu Event Guide Main Menu Register
Menu AGENDA Main Menu Speakers Main Menu Partners

Extract More Value from Predictable Preclinical Data to Enhance Translational Decision Making

With huge investments in oncology drug development, the overall sustainability of high clinical failure rates remains low. Today, more than ever, it’s critical to harness predictive, well characterised preclinical models to bridge the translational gap into the clinic.

As part of the trusted Tumour Model series, Tumour Models London is back to support Pharma, Biotech, and Academic Institutions to best translate next generation In Vitro and In Vivo preclinical learnings to the clinic. As 2017 comes to a close, join the most trusted and assured meeting dedicated to help you predict the clinical outcome of your drug candidates more accurately in 2018.

Download the full programme to see how we can help you predict the clinical outcome of your drug candidates more accurately.

TN 3D

 

PART OF TUMOR MODELS SERIES

Tumor models SF logo   Tumor Models Boston Logo no year